ANPCF
Price
$0.11
Change
-$0.05 (-31.25%)
Updated
Jun 27 closing price
Capitalization
48.56M
CATX
Price
$3.68
Change
+$0.29 (+8.55%)
Updated
Jul 3 closing price
Capitalization
751.25M
33 days until earnings call
Interact to see
Advertisement

ANPCF vs CATX

Header iconANPCF vs CATX Comparison
Open Charts ANPCF vs CATXBanner chart's image
ANGLE
Price$0.11
Change-$0.05 (-31.25%)
Volume$8K
Capitalization48.56M
Perspective Therapeutics
Price$3.68
Change+$0.29 (+8.55%)
Volume$511.2K
Capitalization751.25M
ANPCF vs CATX Comparison Chart in %
Loading...
ANPCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CATX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANPCF vs. CATX commentary
Jul 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANPCF is a Hold and CATX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 06, 2025
Stock price -- (ANPCF: $0.11 vs. CATX: $3.68)
Brand notoriety: ANPCF and CATX are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ANPCF: 570% vs. CATX: 42%
Market capitalization -- ANPCF: $48.56M vs. CATX: $751.25M
ANPCF [@Medical Specialties] is valued at $48.56M. CATX’s [@Medical Specialties] market capitalization is $751.25M. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANPCF’s FA Score shows that 1 FA rating(s) are green whileCATX’s FA Score has 0 green FA rating(s).

  • ANPCF’s FA Score: 1 green, 4 red.
  • CATX’s FA Score: 0 green, 5 red.
According to our system of comparison, CATX is a better buy in the long-term than ANPCF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANPCF’s TA Score shows that 0 TA indicator(s) are bullish while CATX’s TA Score has 4 bullish TA indicator(s).

  • ANPCF’s TA Score: 0 bullish, 5 bearish.
  • CATX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CATX is a better buy in the short-term than ANPCF.

Price Growth

ANPCF (@Medical Specialties) experienced а -34.12% price change this week, while CATX (@Medical Specialties) price change was +1.66% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.93%. For the same industry, the average monthly price growth was +1.81%, and the average quarterly price growth was -0.17%.

Reported Earning Dates

CATX is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Medical Specialties (+1.93% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CATX($751M) has a higher market cap than ANPCF($48.6M). CATX YTD gains are higher at: 15.361 vs. ANPCF (-34.124). ANPCF has higher annual earnings (EBITDA): -15.72M vs. CATX (-39.08M). ANPCF has more cash in the bank: 31.8M vs. CATX (9.24M). ANPCF has less debt than CATX: ANPCF (2.34M) vs CATX (2.55M). ANPCF has higher revenues than CATX: ANPCF (1.01M) vs CATX (0).
ANPCFCATXANPCF / CATX
Capitalization48.6M751M6%
EBITDA-15.72M-39.08M40%
Gain YTD-34.12415.361-222%
P/E RatioN/AN/A-
Revenue1.01M0-
Total Cash31.8M9.24M344%
Total Debt2.34M2.55M92%
FUNDAMENTALS RATINGS
ANPCF vs CATX: Fundamental Ratings
ANPCF
CATX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
35
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9696
PRICE GROWTH RATING
1..100
9340
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ANPCF's Valuation (33) in the null industry is in the same range as CATX (35) in the Biotechnology industry. This means that ANPCF’s stock grew similarly to CATX’s over the last 12 months.

ANPCF's Profit vs Risk Rating (100) in the null industry is in the same range as CATX (100) in the Biotechnology industry. This means that ANPCF’s stock grew similarly to CATX’s over the last 12 months.

ANPCF's SMR Rating (96) in the null industry is in the same range as CATX (96) in the Biotechnology industry. This means that ANPCF’s stock grew similarly to CATX’s over the last 12 months.

CATX's Price Growth Rating (40) in the Biotechnology industry is somewhat better than the same rating for ANPCF (93) in the null industry. This means that CATX’s stock grew somewhat faster than ANPCF’s over the last 12 months.

CATX's P/E Growth Rating (100) in the Biotechnology industry is in the same range as ANPCF (100) in the null industry. This means that CATX’s stock grew similarly to ANPCF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANPCFCATX
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
87%
Stochastic
ODDS (%)
N/A
Bullish Trend 4 days ago
81%
Momentum
ODDS (%)
Bearish Trend 4 days ago
25%
Bullish Trend 4 days ago
76%
MACD
ODDS (%)
Bearish Trend 4 days ago
11%
Bearish Trend 4 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
30%
Bullish Trend 4 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
16%
Bullish Trend 4 days ago
79%
Advances
ODDS (%)
N/A
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
N/A
Bearish Trend 6 days ago
88%
BollingerBands
ODDS (%)
N/A
Bearish Trend 4 days ago
90%
Aroon
ODDS (%)
N/A
Bullish Trend 4 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
ANPCF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CATX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IRLSX76.840.85
+1.12%
Voya Russell Large Cap Growth Idx Port S
RFIMX7.260.07
+0.97%
Ranger Micro Cap Institutional
NCBVX20.930.14
+0.67%
PGIM Quant Solutions Mid-Cap Val C
GCVTX24.340.15
+0.62%
Goldman Sachs Large Cp Val Insghts Inv
VASVX28.650.11
+0.39%
Vanguard Selected Value Inv

ANPCF and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANPCF has been loosely correlated with ANPCY. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ANPCF jumps, then ANPCY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANPCF
1D Price
Change %
ANPCF100%
N/A
ANPCY - ANPCF
58%
Loosely correlated
N/A
CATX - ANPCF
26%
Poorly correlated
+8.55%
BLOZF - ANPCF
21%
Poorly correlated
-0.80%
ADMT - ANPCF
5%
Poorly correlated
-6.20%
AMBBY - ANPCF
1%
Poorly correlated
N/A
More

CATX and

Correlation & Price change

A.I.dvisor indicates that over the last year, CATX has been closely correlated with STRR. These tickers have moved in lockstep 88% of the time. This A.I.-generated data suggests there is a high statistical probability that if CATX jumps, then STRR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CATX
1D Price
Change %
CATX100%
+8.55%
STRR - CATX
88%
Closely correlated
+0.51%
SHC - CATX
34%
Loosely correlated
+0.90%
MTD - CATX
29%
Poorly correlated
+0.28%
OFIX - CATX
28%
Poorly correlated
+0.54%
DHR - CATX
28%
Poorly correlated
+0.35%
More